ESCI award lecture: Regulation, function and biomarker potential of DNA methylation

European Journal of Clinical Investigation

Volumn 45, Issue 3, 2015, Pages 288-293

  Schübeler, Dirk ^a,b  

^a FRIEDRICH MIESCHER INSTITUTE FOR BIOMEDICAL RESEARCH   (Switzerland)

^b UNIVERSITY OF BASEL   (Switzerland)

Author keywords

Biomarker; DNA methylation; Epigenome; Functional genomics; Gene regulation

Indexed keywords

BIOLOGICAL MARKER; DNA; GENOMIC DNA;

CELL DIFFERENTIATION; CPG ISLAND; DEAMINATION; DNA METHYLATION; DNA MODIFICATION; DNA REPAIR; DNA SEQUENCE; GENE CONTROL; GENETIC ASSOCIATION; GENETIC TRANSCRIPTION; NEXT GENERATION SEQUENCING; PRIORITY JOURNAL; REGULATORY DNA SEQUENCE; REVIEW; CHROMOSOMAL MAPPING; GENE EXPRESSION REGULATION; HUMAN; METABOLISM; PHYSIOLOGY; PROCEDURES;

BIOMARKERS; CHROMOSOME MAPPING; CPG ISLANDS; DNA METHYLATION; GENE EXPRESSION REGULATION; HUMANS;

EID: 84923401742     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/eci.12403     Document Type: Review

References (71)

1. Bell O, Tiwari VK, Thoma NH, Schubeler D. Determinants and dynamics of genome accessibility. Nat Rev Genet 2011;12:554-64.
2. Ptashne M. On the use of the word 'epigenetic'. Curr Biol 2007;17:R233-6.
3. Bird A. Perceptions of epigenetics. Nature 2007;447:396-8.
4. Law JA, Jacobsen SE. Establishing, maintaining and modifying DNA methylation patterns in plants and animals. Nat Rev Genet 2010;11:204-20.
5. Okano M, Xie S, Li E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat Genet 1998;19:219-20.
6. Bestor T, Laudano A, Mattaliano R, Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl-terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol 1988;203:971-83.
7. Okano M, Bell DW, Haber DA, Li E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 1999;99:247-57.
8. Bhutani N, Burns DM, Blau HM. DNA demethylation dynamics. Cell 2011;146:866-72.
9. Holliday R, Pugh JE. DNA modification mechanisms and gene activity during development. Science 1975;187:226-32.
10. Riggs AD. X inactivation, differentiation, and DNA methylation. Cytogenet Cell Genet 1975;14:9-25.
11. Baubec T, Schubeler D. Genomic patterns and context specific interpretation of DNA methylation. Curr Opin Genet Dev 2014;25C:85-92.
12. Feng S, Jacobsen SE, Reik W. Epigenetic reprogramming in plant and animal development. Science 2010;330:622-7.
13. Klug M, Heinz S, Gebhard C, Schwarzfischer L, Krause SW, Andreesen R et al. Active DNA demethylation in human postmitotic cells correlates with activating histone modifications, but not transcription levels. Genome Biol 2010;11:R63.
14. Ooi SK, Bestor TH. The colorful history of active DNA demethylation. Cell 2008;133:1145-8.
15. Tahiliani M, Koh KP, Shen Y, Pastor WA, Bandukwala H, Brudno Y et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 2009;324:930-5.
16. Booth MJ, Branco MR, Ficz G, Oxley D, Krueger F, Reik W et al. Quantitative sequencing of 5-methylcytosine and 5-hydroxymethylcytosine at single-base resolution. Science 2012;336:934-7.
17. Yu M, Hon GC, Szulwach KE, Song CX, Zhang L, Kim A et al. Base-resolution analysis of 5-hydroxymethylcytosine in the mammalian genome. Cell 2012;149:1368-80.
18. Klug M, Schmidhofer S, Gebhard C, Andreesen R, Rehli M. 5-Hydroxymethylcytosine is an essential intermediate of active DNA demethylation processes in primary human monocytes. Genome Biol 2013;14:R46.
19. Szwagierczak A, Bultmann S, Schmidt CS, Spada F, Leonhardt H. Sensitive enzymatic quantification of 5-hydroxymethylcytosine in genomic DNA. Nucleic Acids Res 2010;38:e181.
20. Yisraeli J, Frank D, Razin A, Cedar H. Effect of in vitro DNA methylation on beta-globin gene expression. Proc Natl Acad Sci U S A 1988;85:4638-42.
21. Boyes J, Bird A. Repression of genes by DNA methylation depends on CpG density and promoter strength: evidence for involvement of a methyl-CpG binding protein. EMBO J 1992;11:327-33.
22. Schubeler D, Lorincz MC, Cimbora DM, Telling A, Feng YQ, Bouhassira EE et al. Genomic targeting of methylated DNA: influence of methylation on transcription, replication, chromatin structure, and histone acetylation. Mol Cell Biol 2000;20:9103-12.
23. Baubec T, Ivanek R, Lienert F, Schubeler D. Methylation-dependent and -independent genomic targeting principles of the MBD protein family. Cell 2013;153:480-92.
24. Hendrich B, Bird A. Identification and characterization of a family of mammalian methyl-CpG binding proteins. Mol Cell Biol 1998;18:6538-47.
25. Nan X, Ng HH, Johnson CA, Laherty CD, Turner BM, Eisenman RN et al. Transcriptional repression by the methyl-CpG-binding protein MeCP2 involves a histone deacetylase complex. Nature 1998;393:386-9.
26. Zhang Y, Ng HH, Erdjument-Bromage H, Tempst P, Bird A, Reinberg D. Analysis of the NuRD subunits reveals a histone deacetylase core complex and a connection with DNA methylation. Genes Dev 1999;13:1924-35.
27. Lyst MJ, Ekiert R, Ebert DH, Merusi C, Nowak J, Selfridge J et al. Rett syndrome mutations abolish the interaction of MeCP2 with the NCoR/SMRT co-repressor. Nat Neurosci 2013;16:898-902.
28. Iurlaro M, Ficz G, Oxley D, Raiber EA, Bachman M, Booth MJ et al. A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol 2013;14:R119.
29. Spruijt CG, Gnerlich F, Smits AH, Pfaffeneder T, Jansen PW, Bauer C et al. Dynamic readers for 5-(hydroxy)methylcytosine and its oxidized derivatives. Cell 2013;152:1146-59.
30. Bell AC, Felsenfeld G. Methylation of a CTCF-dependent boundary controls imprinted expression of the Igf2 gene. Nature 2000;405:482-5.
31. Hu S, Wan J, Su Y, Song Q, Zeng Y, Nguyen HN et al. DNA methylation presents distinct binding sites for human transcription factors. Elife 2013;2:e00726.
32. Jolma A, Yan J, Whitington T, Toivonen J, Nitta KR, Rastas P et al. DNA-binding specificities of human transcription factors. Cell 2013;152:327-39.
33. Long HK, Sims D, Heger A, Blackledge NP, Kutter C, Wright ML et al. Epigenetic conservation at gene regulatory elements revealed by non-methylated DNA profiling in seven vertebrates. Elife 2013;2:e00348.
34. Deaton AM, Bird A. CpG islands and the regulation of transcription. Genes Dev 2011;25:1010-22.
35. Weber M, Hellmann I, Stadler MB, Ramos L, Paabo S, Rebhan M et al. Distribution, silencing potential and evolutionary impact of promoter DNA methylation in the human genome. Nat Genet 2007;39:457-66.
36. Mohn F, Schubeler D. Genetics and epigenetics: stability and plasticity during cellular differentiation. Trends Genet 2009;25:129-36.
37. Larsen F, Gundersen G, Lopez R, Prydz H. CpG islands as gene markers in the human genome. Genomics 1992;13:1095-107.
38. Shen Y, Yue F, McCleary DF, Ye Z, Edsall L, Kuan S et al. A map of the cis-regulatory sequences in the mouse genome. Nature 2012;488:116-20.
39. Butler JE, Kadonaga JT. The RNA polymerase II core promoter: a key component in the regulation of gene expression. Genes Dev 2002;16:2583-92.
40. Ooi SK, Qiu C, Bernstein E, Li K, Jia D, Yang Z et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 2007;448:714-7.
41. Thomson JP, Skene PJ, Selfridge J, Clouaire T, Guy J, Webb S et al. CpG islands influence chromatin structure via the CpG-binding protein Cfp1. Nature 2010;464:1082-6.
42. Xu Y, Wu F, Tan L, Kong L, Xiong L, Deng J et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol Cell 2011;42:451-64.
43. Xu Y, Xu C, Kato A, Tempel W, Abreu JG, Bian C et al. Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for Xenopus eye and neural development. Cell 2012;151:1200-13.
44. You JS, Jones PA. Cancer genetics and epigenetics: two sides of the same coin? Cancer Cell 2012;22:9-20.
45. Azad N, Zahnow CA, Rudin CM, Baylin SB. The future of epigenetic therapy in solid tumours-lessons from the past. Nat Rev Clin Oncol 2013;10:256-66.
46. Bird AP, Southern EM. Use of restriction enzymes to study eukaryotic DNA methylation: I. The methylation pattern in ribosomal DNA from Xenopus laevis. J Mol Biol 1978;118:27-47.
47. Blackledge NP, Long HK, Zhou JC, Kriaucionis S, Patient R, Klose RJ. Bio-CAP: a versatile and highly sensitive technique to purify and characterise regions of non-methylated DNA. Nucleic Acids Res 2012;40:e32.
48. Cross SH, Charlton JA, Nan X, Bird AP. Purification of CpG islands using a methylated DNA binding column. Nat Genet 1994;6:236-44.
49. Weber M, Davies JJ, Wittig D, Oakeley EJ, Haase M, Lam WL et al. Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat Genet 2005;37:853-62.
50. Frommer M, McDonald LE, Millar DS, Collis CM, Watt F, Grigg GW et al. A genomic sequencing protocol that yields a positive display of 5-methylcytosine residues in individual DNA strands. Proc Natl Acad Sci U S A 1992;89:1827-31.
51. Wang RY, Gehrke CW, Ehrlich M. Comparison of bisulfite modification of 5-methyldeoxycytidine and deoxycytidine residues. Nucleic Acids Res 1980;8:4777-90.
52. Lister R, Pelizzola M, Dowen RH, Hawkins RD, Hon G, Tonti-Filippini J et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 2009;462:315-22.
53. Satterlee JS, Schubeler D, Ng HH. Tackling the epigenome: challenges and opportunities for collaboration. Nat Biotechnol 2010;28:1039-44.
54. Stadler MB, Murr R, Burger L, Ivanek R, Lienert F, Scholer A et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 2011;480:490-5.
55. Wiench M, John S, Baek S, Johnson TA, Sung MH, Escobar T et al. DNA methylation status predicts cell type-specific enhancer activity. EMBO J 2011;30:3028-39.
56. Hodges E, Molaro A, Dos Santos CO, Thekkat P, Song Q, Uren PJ et al. Directional DNA methylation changes and complex intermediate states accompany lineage specificity in the adult hematopoietic compartment. Mol Cell 2011;44:17-28.
57. Schilling E, El Chartouni C, Rehli M. Allele-specific DNA methylation in mouse strains is mainly determined by cis-acting sequences. Genome Res 2009;19:2028-35.
58. Burger L, Gaidatzis D, Schubeler D, Stadler MB. Identification of active regulatory regions from DNA methylation data. Nucleic Acids Res 2013;41:e155.
59. Schillebeeckx M, Schrade A, Lobs AK, Pihlajoki M, Wilson DB, Mitra RD. Laser capture microdissection-reduced representation bisulfite sequencing (LCM-RRBS) maps changes in DNA methylation associated with gonadectomy-induced adrenocortical neoplasia in the mouse. Nucleic Acids Res 2013;41:e116.
60. Rakyan VK, Down TA, Balding DJ, Beck S. Identification of type 1 diabetes-associated DNA methylation variable positions that precede disease diagnosis. PLoS Genet 2011;7:e1002300.
61. Rakyan VK, Down TA, Balding DJ, Beck S. Epigenome-wide association studies for common human diseases. Nat Rev Genet 2011;12:529-41.
62. Weller M, Stupp R, Reifenberger G, Brandes AA, van den Bent MJ, Wick W et al. MGMT promoter methylation in malignant gliomas: ready for personalized medicine? Nat Rev Neurol 2010;6:39-51.
63. Caren H, Pollard SM, Beck S. The good, the bad and the ugly: epigenetic mechanisms in glioblastoma. Mol Aspects Med 2013;34:849-62.
64. Jacquemont S, Curie A, des PV, Torrioli MG, Berry-Kravis E, Hagerman RJ et al. Epigenetic modification of the FMR1 gene in fragile X syndrome is associated with differential response to the mGluR5 antagonist AFQ056. Sci Transl Med 2011;3:64ra61.
65. Bock C. Analysing and interpreting DNA methylation data. Nat Rev Genet 2012;13:705-19.
66. The Cancer Genome Atlas Research Network. Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia. N Engl J Med 2013;368:2059-74.
67. The Cancer Genome Atlas Research Network. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 2013;499:43-9.
68. Beck S, Bernstein BE, Campbell RM, Costello JF, Dhanak D, Ecker JR et al. A blueprint for an international cancer epigenome consortium. A report from the AACR Cancer Epigenome Task Force. Cancer Res 2012;72:6319-24.
69. Gutierrez-Arcelus M, Lappalainen T, Montgomery SB, Buil A, Ongen H, Yurovsky A et al. Passive and active DNA methylation and the interplay with genetic variation in gene regulation. Elife 2013;2:e00523.
70. Michels KB, Binder AM, Dedeurwaerder S, Epstein CB, Greally JM, Gut I et al. Recommendations for the design and analysis of epigenome-wide association studies. Nat Methods 2013;10:949-55.
71. Feldmann A. PhD thesis, University of Basel, 2014.